Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer

NCT07325630 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang Cancer Hospital